Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Hangzhou Tigermed Consulting Co. Ltd

HNGZY
Current price
4.14 USD 0 USD (0.00%)
Last closed 4.14 USD
Company
ISIN unknown
Sector Healthcare
Industry Diagnostics & Research
Exchange PINK
Capitalization 7 608 739 840 USD
Yield for 12 month -64.00 %
1Y
3Y
5Y
10Y
15Y
HNGZY
21.11.2021 - 28.11.2021

Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides product market research, product marketing strategy, product finalization, product verification, registration strategy planning, marketing application, post-marketing supports, and product upgrade services. In addition, the company offers medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, functional services, EDC system, and call center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China. Address: Shengda Science Park, Hangzhou, China, 310051

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

23

Dividend Yield

1.93 %

Current Year

+146 188 203 USD

Last Year

+147 595 211 USD

Current Quarter

+237 228 098 USD

Last Quarter

+232 873 860 USD

Current Year

+55 843 064 USD

Last Year

+58 022 705 USD

Current Quarter

+92 850 658 USD

Last Quarter

+88 105 769 USD

Key Figures HNGZY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 1 692 304 640 USD
Operating Margin TTM 20.4 %
PE Ratio 23
Return On Assets TTM 3.11 %
PEG Ratio
Return On Equity TTM 5.41 %
Wall Street Target Price
Revenue TTM 7 031 433 216 USD
Book Value 24.1 USD
Revenue Per Share TTM
Dividend Share 0.57 USD
Quarterly Revenue Growth YOY -10.9 %
Dividend Yield 1.93 %
Gross Profit TTM 2 808 463 884 USD
Earnings per share 0.18 USD
Diluted Eps TTM 0.18 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -68.4 %
Profit Margin 16.06 %

Dividend Analytics HNGZY

Dividend growth over 5 years

Continuous growth

1 year

Payout Ratio 5 years average

21 %

Dividend History HNGZY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.08
Ex Dividend Date 11.06.2024
Forward Annual Dividend Yield 1.93 %
Last Split Factor
Payout Ratio 44.6 %
Last Split Date
Dividend Date 21.07.2023

Stock Valuation HNGZY

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 23
Forward PE 16.8634
Enterprise Value Revenue 8.2947
Price Sales TTM 1.0821
Enterprise Value EBITDA 28.682
Price Book MRQ 1.2291

Financials HNGZY

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators HNGZY

For 52 weeks

4.12 USD 7.63 USD
50 Day MA 4.16 USD
Shares Short Prior Month
200 Day MA 4.19 USD
Short Ratio
Shares Short
Short Percent